The global Amino Acid Based Infant Formula market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029.
According to World Bank statistics, the global birth rate in 2021 was about 1.7%. Although the population growth rate had slowed down, with the development of the world economy and the increase of per capita disposable income of residents, the spending power is growing. Therefore, there is still a large room for development in the baby products industry. Improving product quality and tapping the value of a single customer will become the drivers for the growth of the infant and child industry. Refinement and diversification are the core characteristics of the consumer demand. China has a large population base, and even if the population growth rate slows down, there will still be a demographic dividend. The State Council in 2022 proposes to "Guide market players to produce safer and healthier domestic infant products". According to the National Bureau of Statistics, China's birth rate in 2022 was 6.77%, and the birth population was 9.56 million. According to the results of the seventh national census in 2021, the number of infants and young children aged 0-6 in China reached 140 million, of which the number of infants and young children aged 3-6 exceeded 70 million. The huge population size has brewed a market demand with huge potential, and the children's consumption market has risen rapidly. Chinese families spend a lot on childcare, with the average cost of childcare ranking second in the world. The survey data released by China Research Center for Children's Industry shows that in 80% of families in China, children's expenditures account for 30% to 50% of household expenditures, and the average annual consumption of children in families is ¥17,000 to 25,500. According to data from the Yuwa Population Research, the national average cost of raising a child (the cost of raising a child to the age of 18) is ¥485,218. From the perspective of specific stages, the largest proportion is the cost of raising children aged 6-14, accounting for about 45%. The cost during pregnancy, the cost of childbirth and confinement, and the cost of raising babies aged 0-2 accounted for 2.06%, 2.09% and 13.33% separately.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Amino Acid Based Infant Formula market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
±·±ð²õ³Ù±ôé
Nutricia
Mead Johnson & Company
Danone
Abbott
Biostime
Synutra
Ajinomoto Health & Nutrition North America.
Segment by Type
First Stage
Second Stage
Third Stage
Segment by Application
Maternal Stores
Supermarkets
Online Retail
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Amino Acid Based Infant Formula report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Âé¶¹Ô´´ Channel and Customer Analysis
Chapter 8: Âé¶¹Ô´´ Opportunities and Challenges
Chapter 9: Âé¶¹Ô´´ Conclusions
Chapter 10: Research Methodology and Data Source
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Amino Acid Based Infant Formula Âé¶¹Ô´´ Overview
1.1 Product Overview and Scope of Amino Acid Based Infant Formula
1.2 Amino Acid Based Infant Formula Segment by Type
1.2.1 Global Amino Acid Based Infant Formula Âé¶¹Ô´´ Value Comparison by Type (2023-2029)
1.2.2 First Stage
1.2.3 Second Stage
1.2.4 Third Stage
1.3 Amino Acid Based Infant Formula Segment by Application
1.3.1 Global Amino Acid Based Infant Formula Âé¶¹Ô´´ Value by Application: (2023-2029)
1.3.2 Maternal Stores
1.3.3 Supermarkets
1.3.4 Online Retail
1.4 Global Amino Acid Based Infant Formula Âé¶¹Ô´´ Size Estimates and Forecasts
1.4.1 Global Amino Acid Based Infant Formula Revenue 2018-2029
1.4.2 Global Amino Acid Based Infant Formula Sales 2018-2029
1.4.3 Global Amino Acid Based Infant Formula Âé¶¹Ô´´ Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Amino Acid Based Infant Formula Âé¶¹Ô´´ Competition by Manufacturers
2.1 Global Amino Acid Based Infant Formula Sales Âé¶¹Ô´´ Share by Manufacturers (2018-2023)
2.2 Global Amino Acid Based Infant Formula Revenue Âé¶¹Ô´´ Share by Manufacturers (2018-2023)
2.3 Global Amino Acid Based Infant Formula Average Price by Manufacturers (2018-2023)
2.4 Global Amino Acid Based Infant Formula Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Amino Acid Based Infant Formula, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Amino Acid Based Infant Formula, Product Type & Application
2.7 Amino Acid Based Infant Formula Âé¶¹Ô´´ Competitive Situation and Trends
2.7.1 Amino Acid Based Infant Formula Âé¶¹Ô´´ Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Amino Acid Based Infant Formula Players Âé¶¹Ô´´ Share by Revenue
2.7.3 Global Amino Acid Based Infant Formula Âé¶¹Ô´´ Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Amino Acid Based Infant Formula Retrospective Âé¶¹Ô´´ Scenario by Region
3.1 Global Amino Acid Based Infant Formula Âé¶¹Ô´´ Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Amino Acid Based Infant Formula Global Amino Acid Based Infant Formula Sales by Region: 2018-2029
3.2.1 Global Amino Acid Based Infant Formula Sales by Region: 2018-2023
3.2.2 Global Amino Acid Based Infant Formula Sales by Region: 2024-2029
3.3 Global Amino Acid Based Infant Formula Global Amino Acid Based Infant Formula Revenue by Region: 2018-2029
3.3.1 Global Amino Acid Based Infant Formula Revenue by Region: 2018-2023
3.3.2 Global Amino Acid Based Infant Formula Revenue by Region: 2024-2029
3.4 North America Amino Acid Based Infant Formula Âé¶¹Ô´´ Facts & Figures by Country
3.4.1 North America Amino Acid Based Infant Formula Âé¶¹Ô´´ Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Amino Acid Based Infant Formula Sales by Country (2018-2029)
3.4.3 North America Amino Acid Based Infant Formula Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Amino Acid Based Infant Formula Âé¶¹Ô´´ Facts & Figures by Country
3.5.1 Europe Amino Acid Based Infant Formula Âé¶¹Ô´´ Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Amino Acid Based Infant Formula Sales by Country (2018-2029)
3.5.3 Europe Amino Acid Based Infant Formula Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Amino Acid Based Infant Formula Âé¶¹Ô´´ Facts & Figures by Country
3.6.1 Asia Pacific Amino Acid Based Infant Formula Âé¶¹Ô´´ Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Amino Acid Based Infant Formula Sales by Country (2018-2029)
3.6.3 Asia Pacific Amino Acid Based Infant Formula Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Amino Acid Based Infant Formula Âé¶¹Ô´´ Facts & Figures by Country
3.7.1 Latin America Amino Acid Based Infant Formula Âé¶¹Ô´´ Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Amino Acid Based Infant Formula Sales by Country (2018-2029)
3.7.3 Latin America Amino Acid Based Infant Formula Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Amino Acid Based Infant Formula Âé¶¹Ô´´ Facts & Figures by Country
3.8.1 Middle East and Africa Amino Acid Based Infant Formula Âé¶¹Ô´´ Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Amino Acid Based Infant Formula Sales by Country (2018-2029)
3.8.3 Middle East and Africa Amino Acid Based Infant Formula Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Amino Acid Based Infant Formula Sales by Type (2018-2029)
4.1.1 Global Amino Acid Based Infant Formula Sales by Type (2018-2023)
4.1.2 Global Amino Acid Based Infant Formula Sales by Type (2024-2029)
4.1.3 Global Amino Acid Based Infant Formula Sales Âé¶¹Ô´´ Share by Type (2018-2029)
4.2 Global Amino Acid Based Infant Formula Revenue by Type (2018-2029)
4.2.1 Global Amino Acid Based Infant Formula Revenue by Type (2018-2023)
4.2.2 Global Amino Acid Based Infant Formula Revenue by Type (2024-2029)
4.2.3 Global Amino Acid Based Infant Formula Revenue Âé¶¹Ô´´ Share by Type (2018-2029)
4.3 Global Amino Acid Based Infant Formula Price by Type (2018-2029)
5 Segment by Application
5.1 Global Amino Acid Based Infant Formula Sales by Application (2018-2029)
5.1.1 Global Amino Acid Based Infant Formula Sales by Application (2018-2023)
5.1.2 Global Amino Acid Based Infant Formula Sales by Application (2024-2029)
5.1.3 Global Amino Acid Based Infant Formula Sales Âé¶¹Ô´´ Share by Application (2018-2029)
5.2 Global Amino Acid Based Infant Formula Revenue by Application (2018-2029)
5.2.1 Global Amino Acid Based Infant Formula Revenue by Application (2018-2023)
5.2.2 Global Amino Acid Based Infant Formula Revenue by Application (2024-2029)
5.2.3 Global Amino Acid Based Infant Formula Revenue Âé¶¹Ô´´ Share by Application (2018-2029)
5.3 Global Amino Acid Based Infant Formula Price by Application (2018-2029)
6 Key Companies Profiled
6.1 ±·±ð²õ³Ù±ôé
6.1.1 ±·±ð²õ³Ù±ôé Corporation Information
6.1.2 ±·±ð²õ³Ù±ôé Description and Business Overview
6.1.3 ±·±ð²õ³Ù±ôé Amino Acid Based Infant Formula Sales, Revenue and Gross Margin (2018-2023)
6.1.4 ±·±ð²õ³Ù±ôé Amino Acid Based Infant Formula Product Portfolio
6.1.5 ±·±ð²õ³Ù±ôé Recent Developments/Updates
6.2 Nutricia
6.2.1 Nutricia Corporation Information
6.2.2 Nutricia Description and Business Overview
6.2.3 Nutricia Amino Acid Based Infant Formula Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Nutricia Amino Acid Based Infant Formula Product Portfolio
6.2.5 Nutricia Recent Developments/Updates
6.3 Mead Johnson & Company
6.3.1 Mead Johnson & Company Corporation Information
6.3.2 Mead Johnson & Company Description and Business Overview
6.3.3 Mead Johnson & Company Amino Acid Based Infant Formula Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Mead Johnson & Company Amino Acid Based Infant Formula Product Portfolio
6.3.5 Mead Johnson & Company Recent Developments/Updates
6.4 Danone
6.4.1 Danone Corporation Information
6.4.2 Danone Description and Business Overview
6.4.3 Danone Amino Acid Based Infant Formula Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Danone Amino Acid Based Infant Formula Product Portfolio
6.4.5 Danone Recent Developments/Updates
6.5 Abbott
6.5.1 Abbott Corporation Information
6.5.2 Abbott Description and Business Overview
6.5.3 Abbott Amino Acid Based Infant Formula Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Abbott Amino Acid Based Infant Formula Product Portfolio
6.5.5 Abbott Recent Developments/Updates
6.6 Biostime
6.6.1 Biostime Corporation Information
6.6.2 Biostime Description and Business Overview
6.6.3 Biostime Amino Acid Based Infant Formula Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Biostime Amino Acid Based Infant Formula Product Portfolio
6.6.5 Biostime Recent Developments/Updates
6.7 Synutra
6.6.1 Synutra Corporation Information
6.6.2 Synutra Description and Business Overview
6.6.3 Synutra Amino Acid Based Infant Formula Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Synutra Amino Acid Based Infant Formula Product Portfolio
6.7.5 Synutra Recent Developments/Updates
6.8 Ajinomoto Health & Nutrition North America.
6.8.1 Ajinomoto Health & Nutrition North America. Corporation Information
6.8.2 Ajinomoto Health & Nutrition North America. Description and Business Overview
6.8.3 Ajinomoto Health & Nutrition North America. Amino Acid Based Infant Formula Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Ajinomoto Health & Nutrition North America. Amino Acid Based Infant Formula Product Portfolio
6.8.5 Ajinomoto Health & Nutrition North America. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Amino Acid Based Infant Formula Industry Chain Analysis
7.2 Amino Acid Based Infant Formula Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Amino Acid Based Infant Formula Production Mode & Process
7.4 Amino Acid Based Infant Formula Sales and Âé¶¹Ô´´ing
7.4.1 Amino Acid Based Infant Formula Sales Channels
7.4.2 Amino Acid Based Infant Formula Distributors
7.5 Amino Acid Based Infant Formula Customers
8 Amino Acid Based Infant Formula Âé¶¹Ô´´ Dynamics
8.1 Amino Acid Based Infant Formula Industry Trends
8.2 Amino Acid Based Infant Formula Âé¶¹Ô´´ Drivers
8.3 Amino Acid Based Infant Formula Âé¶¹Ô´´ Challenges
8.4 Amino Acid Based Infant Formula Âé¶¹Ô´´ Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Âé¶¹Ô´´ Size Estimation
10.1.3 Âé¶¹Ô´´ Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
±·±ð²õ³Ù±ôé
Nutricia
Mead Johnson & Company
Danone
Abbott
Biostime
Synutra
Ajinomoto Health & Nutrition North America.
Ìý
Ìý
*If Applicable.